Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments:... Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with a focus on central nervous system and endocrine disorders, including Parkinson’s disease. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson’s disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT, which is use for the treatment of Parkinson’s disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.83 | 6.39938319198 | 12.97 | 13.8 | 12.49 | 1721643 | 13.03040958 | CS |
| 4 | 0.18 | 1.32158590308 | 13.62 | 13.81 | 11.76 | 1594329 | 12.64477252 | CS |
| 12 | 1.54 | 12.5611745514 | 12.26 | 13.92 | 11.71 | 1618877 | 12.63424938 | CS |
| 26 | 1.79 | 14.9042464613 | 12.01 | 15.42 | 11.71 | 2076084 | 13.23345408 | CS |
| 52 | 6.6 | 91.6666666667 | 7.2 | 15.42 | 7.07 | 1872115 | 11.60335213 | CS |
| 156 | 7.92 | 134.693877551 | 5.88 | 15.42 | 5.01 | 1620155 | 9.33245771 | CS |
| 260 | 7.92 | 134.693877551 | 5.88 | 15.42 | 5.01 | 1620155 | 9.33245771 | CS |
ron_66271
9分前
Genz2
10分前
ron_66271
10分前
ron_66271
31分前
raiderz
1時間前
Dorick
1時間前
dinogreeves
1時間前
dinogreeves
1時間前
dinogreeves
1時間前
Genz2
1時間前
thistraderknowsall
2時間前
walterc
2時間前
satter
2時間前
Investor082
2時間前
barnstormer
2時間前
Investor082
2時間前
Investor082
2時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。